Cost Effectiveness of Vaccinating Against Lyme Disease
Author Information
Author(s): Martin I. Meltzer, David T. Dennis, Kathleen A. Orloski
Primary Institution: Centers for Disease Control and Prevention
Hypothesis
What is the cost effectiveness of using a vaccine to protect against Lyme disease in the United States?
Conclusion
Vaccination against Lyme disease can be cost-effective, particularly for individuals at higher risk of contracting the disease.
Supporting Evidence
- Vaccination costs were estimated at $50, $100, and $200 per year.
- The mean cost per case averted was $4,466 with a 0.005 probability of contracting Lyme disease.
- Vaccination resulted in net savings when the probability of contracting Lyme disease was higher.
- Vaccine efficacy was assumed to be 85%, maximizing estimated economic benefits.
Takeaway
This study looks at how much it costs to prevent Lyme disease with a vaccine, showing that it can save money for people at risk.
Methodology
A decision tree model was used to evaluate the cost per case averted by vaccinating against Lyme disease, incorporating various probabilities and costs.
Limitations
The study relies on unvalidated or unavailable data for many inputs, which may affect the accuracy of the cost-effectiveness estimates.
Statistical Information
Confidence Interval
95% CI: 14% to 71%
Want to read the original?
Access the complete publication on the publisher's website